Class information for:
Level 1: DOPAMINE D 3 RECEPTOR//D 3 RECEPTOR//7 OH DPAT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3313 2013 45.5 85%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
76 3       NEUROSCIENCES//DOPAMINE//SEROTONIN 81359
75 2             NUCLEUS ACCUMBENS//DOPAMINE//COCAINE 27976
3313 1                   DOPAMINE D 3 RECEPTOR//D 3 RECEPTOR//7 OH DPAT 2013

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DOPAMINE D 3 RECEPTOR authKW 1995397 10% 63% 209
2 D 3 RECEPTOR authKW 963916 5% 67% 95
3 7 OH DPAT authKW 689753 4% 60% 76
4 DOPAMINE D 4 RECEPTOR authKW 551491 3% 61% 60
5 D 3 DOPAMINE RECEPTOR authKW 500041 2% 70% 47
6 BP 897 authKW 356670 1% 87% 27
7 CARIPRAZINE authKW 339737 1% 80% 28
8 DOPAMINE RECEPTORS authKW 274531 10% 9% 199
9 NAFADOTRIDE authKW 269802 1% 68% 26
10 SB 277011A authKW 263774 1% 87% 20

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Neurosciences 10821 43% 0% 866
2 Pharmacology & Pharmacy 9265 40% 0% 809
3 Chemistry, Medicinal 6696 18% 0% 353
4 Psychiatry 1936 12% 0% 243
5 Behavioral Sciences 780 5% 0% 98
6 Biochemistry & Molecular Biology 502 17% 0% 347
7 Chemistry, Organic 411 8% 0% 162
8 Clinical Neurology 105 5% 0% 96
9 Substance Abuse 64 1% 0% 21
10 Cell Biology 19 4% 0% 77

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MED CHEM SECT 168511 3% 22% 51
2 EMIL FI ER 154052 3% 18% 58
3 MOL TARGETS MEDICAT DISCOVERY BRANCH 88287 1% 31% 19
4 UNITE NEUROBIOL PHARMACOL MOL 83543 1% 24% 23
5 EXCELLENCE DRUG DISCOVERY PSYCHIAT 71185 1% 36% 13
6 THOMAS H CHRISTOPHER PARKINSONS DIS 64706 0% 53% 8
7 RECH SERVIER 55444 1% 23% 16
8 PHARMACOL MED CHEM PSYCHIAT 54166 0% 71% 5
9 NEUROPSYCHOPHARMACOL SECT 52420 1% 31% 11
10 ADDICT IMAGING GRP 43865 0% 32% 9

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SYNAPSE 8486 2% 1% 43
2 JOURNAL OF MEDICINAL CHEMISTRY 8272 5% 1% 109
3 BEHAVIOURAL PHARMACOLOGY 6988 1% 2% 30
4 EUROPEAN JOURNAL OF PHARMACOLOGY 6523 6% 0% 111
5 NEUROPSYCHOPHARMACOLOGY 6261 2% 1% 46
6 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 5776 5% 0% 99
7 PSYCHOPHARMACOLOGY 5215 3% 1% 65
8 NEUROPHARMACOLOGY 4822 3% 1% 55
9 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 4276 4% 0% 78
10 POLISH JOURNAL OF PHARMACOLOGY 3291 1% 2% 12

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 DOPAMINE D 3 RECEPTOR 1995397 10% 63% 209 Search DOPAMINE+D+3+RECEPTOR Search DOPAMINE+D+3+RECEPTOR
2 D 3 RECEPTOR 963916 5% 67% 95 Search D+3+RECEPTOR Search D+3+RECEPTOR
3 7 OH DPAT 689753 4% 60% 76 Search 7+OH+DPAT Search 7+OH+DPAT
4 DOPAMINE D 4 RECEPTOR 551491 3% 61% 60 Search DOPAMINE+D+4+RECEPTOR Search DOPAMINE+D+4+RECEPTOR
5 D 3 DOPAMINE RECEPTOR 500041 2% 70% 47 Search D+3+DOPAMINE+RECEPTOR Search D+3+DOPAMINE+RECEPTOR
6 BP 897 356670 1% 87% 27 Search BP+897 Search BP+897
7 CARIPRAZINE 339737 1% 80% 28 Search CARIPRAZINE Search CARIPRAZINE
8 DOPAMINE RECEPTORS 274531 10% 9% 199 Search DOPAMINE+RECEPTORS Search DOPAMINE+RECEPTORS
9 NAFADOTRIDE 269802 1% 68% 26 Search NAFADOTRIDE Search NAFADOTRIDE
10 SB 277011A 263774 1% 87% 20 Search SB+277011A Search SB+277011A

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 BOECKLER, F , GMEINER, P , (2006) THE STRUCTURAL EVOLUTION OF DOPAMINE D-3 RECEPTOR LIGANDS: STRUCTURE-ACTIVITY RELATIONSHIPS AND SELECTED NEUROPHARMACOLOGICAL ASPECTS.PHARMACOLOGY & THERAPEUTICS. VOL. 112. ISSUE 1. P. 281-333 223 59% 53
2 SOKOLOFF, P , LE FOLL, B , (2017) THE DOPAMINE D3 RECEPTOR, A QUARTER CENTURY LATER.EUROPEAN JOURNAL OF NEUROSCIENCE. VOL. 45. ISSUE 1. P. 2 -19 111 56% 1
3 HEIDBREDER, CA , GARDNER, EL , XI, ZX , THANOS, PK , MUGNAINI, M , HAGAN, JJ , ASHBY, CR , (2005) THE ROLE OF CENTRAL DOPAMINE D-3 RECEPTORS IN DRUG ADDICTION: A REVIEW OF PHARMACOLOGICAL EVIDENCE.BRAIN RESEARCH REVIEWS. VOL. 49. ISSUE 1. P. 77-105 169 59% 182
4 LEVANT, B , (1997) THE D-3 DOPAMINE RECEPTOR: NEUROBIOLOGY AND POTENTIAL CLINICAL RELEVANCE.PHARMACOLOGICAL REVIEWS. VOL. 49. ISSUE 3. P. 231-252 136 69% 323
5 CORTES, A , MORENO, E , RODRIGUEZ-RUIZ, M , CANELA, EI , CASADO, V , (2016) TARGETING THE DOPAMINE D3 RECEPTOR: AN OVERVIEW OF DRUG DESIGN STRATEGIES.EXPERT OPINION ON DRUG DISCOVERY. VOL. 11. ISSUE 7. P. 641 -664 138 58% 0
6 YE, N , NEUMEYER, JL , BALDESSARINI, RJ , ZHEN, XC , ZHANG, A , (2013) UPDATE 1 OF: RECENT PROGRESS IN DEVELOPMENT OF DOPAMINE RECEPTOR SUBTYPE-SELECTIVE AGENTS: POTENTIAL THERAPEUTICS FOR NEUROLOGICAL AND PSYCHIATRIC DISORDERS.CHEMICAL REVIEWS. VOL. 113. ISSUE . P. PR123 -PR177 154 39% 24
7 LEGGIO, GM , BUCOLO, C , PLATANIA, CBM , SALOMONE, S , DRAGO, F , (2016) CURRENT DRUG TREATMENTS TARGETING DOPAMINE D3 RECEPTOR.PHARMACOLOGY & THERAPEUTICS. VOL. 165. ISSUE . P. 164 -177 105 52% 2
8 SHAFER, RA , LEVANT, B , (1998) THE D-3 DOPAMINE RECEPTOR IN CELLULAR AND ORGANISMAL FUNCTION.PSYCHOPHARMACOLOGY. VOL. 135. ISSUE 1. P. 1 -16 127 71% 84
9 MICHELI, F , HEIDBREDER, C , (2013) DOPAMINE D3 RECEPTOR ANTAGONISTS: A PATENT REVIEW (2007-2012).EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 23. ISSUE 3. P. 363 -381 94 63% 21
10 MILLAN, MJ , SEGUIN, L , GOBERT, A , CUSSAC, D , BROCCO, M , (2004) THE ROLE OF DOPAMINE D-3 COMPARED WITH D-2 RECEPTORS IN THE CONTROL OF LOCOMOTOR ACTIVITY: A COMBINED BEHAVIOURAL AND NEUROCHEMICAL ANALYSIS WITH NOVEL, SELECTIVE ANTAGONISTS IN RATS.PSYCHOPHARMACOLOGY. VOL. 174. ISSUE 3. P. 341-357 90 81% 74

Classes with closest relation at Level 1


Rank Class id link
1 2915 SKF 83959//DIHYDREXIDINE//DOPAMINE D 1 LIKE RECEPTOR
2 8933 DRD2//DRD4//D2 DOPAMINE RECEPTOR GENE
3 12452 OSU6162//ROXINDOLE//TERGURIDE
4 12327 ARIPIPRAZOLE//BLONANSERIN//CONDITIONED AVOIDANCE RESPONSE
5 3690 C 11RACLOPRIDE//F 18FALLYPRIDE//RACLOPRIDE
6 31910 PYRAZOLO1 5 APYRIDINE//CAS 94457 09 7//KC 764
7 10822 AMPEROZIDE//CLOZAPINE//SAVOXEPINE
8 12212 DELAY PERIOD ACTIVITY//PREFRONTAL CORTEX//CORT CIRCUITS COMPUTAT
9 29114 PRAMIPEXOLE//PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE//TALIPEXOLE
10 18005 ARYLPIPERAZINES//5 HT1A LIGANDS//LONG CHAIN ARYLPIPERAZINES

Go to start page